A 26-year-old HIV-infected man presented with fever and disseminated maculopapular rash not involving his palms and soles. He had started antiretroviral therapy (ART) with an abacavir-based regimen three days prior. Although he tested negative for HLA-B\*5701, the antiretrovirals were suspected to be the offending agent associated with the drug eruption. Within several days after discontinuing the ART, his clinical symptoms resided, but a skin rash accompanied by a small ulcer remained on his back ([Picture 1](#g001){ref-type="fig"}). Skin biopsy demonstrated lymphocyte infiltration into the dermis on hematoxylin and eosin staining and *Treponema pallidum* on immunohistochemical staining ([Picture 2](#g002){ref-type="fig"}). His syphilis serological titer was negative, and a prozone phenomenon was excluded. Based on the pathological evidence, penicillin was initiated, leading to a dramatic clinical response. Two months later, his *Treponema pallidum* Latex Agglutination test seroconverted. Physicians need to be aware of the possibility of seronegative secondary syphilis, especially in HIV-infected patients, and skin biopsy should be conducted for refractory skin lesions ([@B1]). In addition, a polymerase chain reaction test with sufficient sensitivity and specificity may facilitate the diagnosis of syphilis ([@B2]).
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